This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Ligand Pharmaceuticals, Inc., Other. Active years: 2000-2001.
Company Filing History:
1 out of 139 
1 out of 834,350 Years Active: 2000-2001
Title: The Innovative Contributions of Stephen G. Miller
Introduction
Stephen G. Miller is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with the G-CSF receptor and the ob gene. With a total of 2 patents, his work has implications for treating various medical conditions.
Latest Patents
Miller's latest patents include innovations in metal complexes, specifically zinc chelated G-CSF receptor ligands. These inventions encompass pharmaceutical compositions containing these compounds and methods for utilizing them as agonists of the G-CSF receptor. Additionally, he has developed novel processes for preparing these compounds and created new G-CSF receptor binding moieties. Another significant patent focuses on modulators of the ob gene, which involves the isolation and cloning of the promoter and control regions of the human ob gene. This invention provides methods for identifying agents that can treat diseases influenced by ob gene expression, including obesity, diabetes, and cardiovascular diseases.
Career Highlights
Throughout his career, Stephen G. Miller has worked with notable companies, including Ligand Pharmaceuticals, Inc. His innovative work has positioned him as a key figure in pharmaceutical research and development.
Collaborations
Miller has collaborated with esteemed colleagues such as Michael R. Briggs and Johan Auwerx, contributing to the advancement of scientific knowledge in his field.
Conclusion
Stephen G. Miller's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.